Methods
ecent epidemiological studies have reported an association between cardiovascular disease (CVD) risk factors and inflammation, [1] [2] [3] and the latter has been recently identified as an independent risk factor for CVD. [4] [5] [6] However, its role in the genesis of CVD remains to be elucidated. The white blood cell (WBC) count is an objective marker of acute infection, tissue damage, and other inflammatory conditions. An increase in the count is closely correlated with advanced atherosclerosis, 7 and the incidence and mortality rate of CVD. [8] [9] [10] [11] [12] [13] Therefore, the WBC count is a CVD risk factor, together with fibrinogen and C-reactive protein (CRP). Because it is included in the blood tests for routine health examinations, the WBC count may be a useful indicator of CVD and the onset of atherosclerosis.
Metabolic syndrome (MS), which comprises various metabolic disorders that are linked on the basis of insulin resistance, is a known risk factor for CVD. [14] [15] [16] Therefore, investigation of the mechanism of the elevated WBC count requires an understanding of the association between the count and each of the MS components related to CVD. Over the years, researchers have included disorders of insulin resistance, obesity, high blood pressure (BP), glucose intolerance, dyslipidemia, hyperuricemia, coagulation disorders, and inflammation in the definition of MS, 17 but recently a definition of the MS components was published in the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (ATP III). 18 In the present study, we studied the association among the normal range of WBC count, insulin concentration, and the clustering of MS components as defined by the ATP III, using data for Japanese men recorded at annual employees' health examinations. questionnaire including medical history, medication use, smoking status, drinking status, and physical activity, underwent a physical examination including height, weight, and blood pressure measured sitting after 5 min rest, and provided overnight fasting blood samples.
Smoking status was classified into 4 levels (never, past and current smoker of 1-24 or ≥25 cigarettes/day). Alcohol drinking status was first assessed by the number of drinking days per week (none, 1-3, 4-6 or daily), then, for those who drank, it was further categorized into 3 levels (light, moderate, and heavy) by weekly consumption obtained as the daily alcohol consumption multiplied by the number of days of drinking per week. Each level approximately corresponded to less than 23, 23-46, and ≥46 grams of ethanol consumption per day, respectively.
We excluded individuals with WBC counts of ≥10,000 cells/ l (n=122), indicating clinically relevant inflammatory conditions. Those with a history of chronic disease such as CVD or stroke were not excluded. Finally, the current analysis was restricted to 3,594 men with complete data on all the components of the MS and the WBC count. All subjects in the study gave their informed consent for the use of personal information for analysis. The Ethics Committee of Nagoya University Graduate School of Medicine, Nagoya, Japan, approved the study protocol.
Biochemical Analyses
Venous blood samples were drawn from the subjects after an 8 h or overnight fast and stored at -80°C until assay. Triglycerides (TG) were determined enzymatically; high density lipoprotein-cholesterol (HDL-C) was measured by the phosphotungstate method; glucose was enzymatically determined by the hexokinase method; insulin concentration was measured by immunoradiometric assay; and the WBC count was determined by automated particle counters within 24 h after venipuncture in a commercial laboratory.
Statistical Analyses
The characteristics of the MS components except obesity were defined by the following cutoff limits as detailed in the ATP III report: 18 (i) high BP: systolic (SBP) ≥130 mmHg and/or diastolic (DBP) ≥85 mmHg and/or medication for hypertension; (ii) hypo-HDL-cholesterolemia: HDL-C <40 mg/dl; hypertriglyceridemia: TG ≥150 mg/dl and/or medication for hyperlipidemia, and (iv) hyperglycemia: fasting plasma glucose ≥110 mg/dl and/or medication for diabetes. For the fifth component of MS, subjects who had a body mass index (BMI), calculated as weight (kilograms) divided by height (meters) squared, of ≥25 kg/m 2 were defined as obese according to the criteria recommended by the Japan Society for the Study of Obesity, 19 because we could not obtain their waist measurements. Subjects with 3 or more of these components were defined as having MS.
Pearson's correlation coefficients were obtained between the value of each of the MS components and the respective WBC count and plasma insulin concentration. Fasting plasma insulin and TG were skewed and were normalized by logarithmic transformation in all analyses. Mean WBC counts were calculated across the categorized components of MS. All mean values were adjusted for years of age by means of a multiple general linear regression model. Further adjustment was performed with smoking status, drinking status and a medical history of stroke, cardiac infarction, cancer, liver disease, asthma or atopy.
Subjects with different numbers of MS components were grouped into 6 subgroups graded by numbers 0-5. Means of WBC counts and log-transformed plasma insulin were then calculated for each subgroup by means of a multiple linear regression model, with adjustment for age, smoking status, drinking status, and medical history as described before. After subjects were grouped into those with and without MS, the means of WBC counts and log-transformed plasma insulin were calculated for each by means of a multiple general linear regression model. Multiple linear regression analysis with the WBC count as the dependent variable, and components of MS and confounding factors as the independent variables was used to identify significant predictors for WBC counts.
All statistical analyses were performed with the SPSS statistical package for Windows version 11.0. 20 All reported p-values were two-sided, and p<0.05 was considered statistically significant.
Results
The characteristics of the subjects and distribution of the MS components among the 3,594 Japanese men are shown in Tables 1 and 2 . Pearson's correlation coefficients between each of the components of MS and each WBC count and log-transformed plasma insulin are shown in Table 3 . There were statistically significant positive correlations (p<0.001) between the WBC count and age, BMI, SBP, DBP, TG, fasting plasma glucose, and fasting plasma insulin. A negative correlation was found between the WBC count and HDL-C. The WBC count had the strongest correlation with TG (r=0.23) and HDL-C (r=-0.24). The insulin concentration had a statistically significant positive correlation with BMI, SBP, DBP, TG, glucose, and WBC count, and showed a significant negative correlation with age and HDL-C. By far the strongest correlation was observed between the insulin concentration and BMI (r=0.53). Table 4 shows the adjusted mean WBC counts for the different groups with respect to the 5 components of MS. The age-adjusted mean WBC counts were significantly higher in obese subjects and those with hypo-HDL-cholesterolemia, hypertriglyceridemia or hyperglycemia than in those without these components, and did not differ between subjects with and without high BP. After further adjustment for smoking status, drinking status, and medical history, the mean WBC counts were still significantly higher in subjects with each of the MS components than in those without (p<0.001 for all).
Only 31.6% of all subjects were free of all 5 components and 16% were diagnosed as having MS (Table 5 ). The multi-adjusted means of insulin concentration and WBC count were significantly higher in MS subjects than in non-MS subjects (p<0.001). Compared with a multi-adjusted WBC mean of 5,758 cells/ l for subjects without any MS components, the means of those with 1, 2, 3, 4, and 5 components were 5,910, 6,136, 6,236, 6,535, and 7,269 cells/ l, respectively, showing a significant increasing trend (p< 0.001 for trend). The log-transformed insulin concentrations also showed a significant increasing trend, together with the increasing number of MS components (p<0.001 for trend). Moreover, multiple linear regression analysis performed with the WBC count as the dependent variable, and with the values of all MS components, a medical history and logtransformed insulin as the independent variables showed that BMI, HDL-C, SBP, glucose and TG had significant and independent associations with the WBC count ( Table 6 ). The insulin concentration was not significantly related to the WBC count. Only 19.7% of the variance in the WBC count was explained by this model. Additional statistical analyses were done by excluding individuals (n=499) with a medical history, but this did not alter the results.
Discussion
Our large, workplace-based sample study of middleaged Japanese men has shown a strong association between the WBC count and MS as defined in ATP III (ie, obesity, high BP, hypertriglyceridemia, hypo-HDL-cholesterolemia, and hyperglycemia) after adjusting for the effects of age, smoking, drinking and medical history associated with low-grade inflammation. Others have reported an association between the WBC count and metabolic disorders. 21 In the CARDIA study, significant positive associations were found between the WBC count and the SBP and BMI, respectively, and a negative correlation was found between the WBC count and HDL-cholesterol. 22 In the ARIC study, significant associations were observed between the WBC count and BP, insulin concentration, TG, and uric acid, 23 respectively. Targher et al investigated the association between the WBC count and CVD risk factors, and reported that a higher WBC count was associated with the clustering of components of insulin resistance syndrome. 24 In a study involving 5,275 middle-aged Japanese male subjects, Nakanishi et al reported that WBC counts adjusted for age, smoking and drinking were significantly higher in obese patients and those with high BP, hypertriglyceridemia, hypercholesterolemia, hypo-HDL-cholesterolemia, glucose intolerance, or hyperuricemia than in the people without these conditions. 25 Similar associations were found in the present study in which MS was defined as 5 disorders according to ATP III.
In the present study, subjects whose WBC count exceeded 10,000 cells/ l, a clinically important cutoff point, were excluded. Thus, only subjects whose WBC count was within the normal range were examined. Unlike other studies, we adjusted not only for age, smoking and drinking status, but also for a previous medical history of a disease associated with low-grade inflammation. Previous studies have mainly focused on associations between the WBC count and a single metabolic disorder such as diabetes, 26 hypertension 27, 28 or hyperlipidemia, 29 but it may also be associated with several of these disorders, so we investigated possible associations between the WBC count and clusters of the 5 components of MS as defined in ATP III. We found that the average WBC count became significantly higher as the number of MS components increased, which suggests that subjects with a single MS component have low-grade inflammation, which intensifies as the number of MS components increases. Although the mechanism by which the WBC count is directly affected by each of the MS components remains unclear, there are several explanations. Vascular endothelial cells are activated by the presence of atherosclerotic risk factors, such as hypertension, hyperlipidemia and hyperglycemia. Endothelial cells produce intracellular adhesion molecule-1, an adhesion molecule, that causes WBCs to adhere to the vascular wall, after which they can penetrate the vascular endothelium and produce new cytokines and chemokines. Cytokines then activate the WBCs and cells comprising the vascular wall, promoting platelet aggregation and thrombus formation. 30 Because proinflammatory cytokines such as tumor necrosis factoralpha (TNF-) and interleukin-6 (IL-6) have been observed in atherosclerotic plaque, 31 inflammation of the vascular wall is considered to play an important role in the onset and progress of atherosclerosis. Proinflammatory cytokines are also known to increase the WBC count. 32 Therefore, we surmise that the count reflects the severity of the inflammation in atherosclerotic lesions, or the severity of atherosclerosis, and that an increase in the WBC count would further exacerbate the inflammation. It has been reported that TNF-and IL-6, which elevate the WBC count, are released from adipose cells and hence are in higher concentrations in obese people. 33, 34 In the present investigation, we found a significantly higher WBC count in the obese compared with non-obese subjects.
We also found a significant rise in the insulin concentration, as well as in the WBC count, in relation to the increased number of MS components. However, multiple linear regression analysis of the WBC counts while simultaneously treating the MS components and the insulin concentration as the independent variables did not show any significant association between insulin concentration and the WBC count. This result suggests that insulin or insulin resistance does not directly increase the WBC count. When the positive relationships between insulin concentrations and MS components shown in Tables 3 and  5 are considered, it is more likely that insulin resistance plays an important role in the genesis of MS and because MS most likely initiates atherosclerosis, 35 it indirectly causes an increase in the WBC count as the atherosclerosis progresses. However, it is possible that MS may directly cause the increase in the WBC count through obesity or by other unknown mechanisms.
We have already reported a positive association of CRP with the clustering of metabolic disorders defined slightly different from those for MS by ATP III. 2 In that study, compared with men who had no components of MS, those who had 1, 2, 3, 4 and 5 or more components were, respectively, 1.48, 1.84, 1.92, 3.42, and 4.17 times more likely to have elevated CRP concentration (CRP ≥0.06 mg/dl). Together with those results, the present findings strongly suggests that inflammation underlies the development of MS. According to recent studies, 36, 37 oxidative stress is a potent factors linking metabolic disorders, WBC count, and CRP. Because the multiple linear regression analysis model we used in the present study explained only 19.7% of the variance in the WBC count, it is possible that many other factors play a role in the increase in the WBC count. Further studies are necessary to elucidate the roles of WBC and CRP in the mechanism underlying MS and atherosclerosis.
Study Limitations
First, although waist circumference is used as the indicator for obesity in the ATP III criteria, those data were not available for the present study. Besides, the criteria for obesity in ATP III may not be suitable for Japanese who are leaner than their Western counterparts. From a study of 1,193 Japanese men, the Japan Society for the Study of Obesity reported that correlation coefficients with visceral fat measured by computed tomography were similar when BMI replaced waist circumference. 17 We therefore concluded that the obesity standard of BMI ≥25 kg/m 2 determined by the Japan Society for the Study of Obesity reflects abdominal obesity in Japanese. Second, the present study was a cross-sectional design, so it was not possible to confirm a cause and effect relationship between the increase in the WBC count and the presence of MS components or atherosclerosis. Third, our study investigated the possible association of the WBC count with insulin concentration, but not with insulin resistance. Fourth, the subjects in the present study were Japanese men, and the findings may not be applicable to women or other races with different physical characteristics. Finally, we did not have data on the fractions of the WBC. Two previous studies have shown that reactive oxygen species formation by polymorphonuclear cells (PMNs) is related to hemoglobinA1c, but not to blood glucose. 36, 37 One was a hospitalbased study and the mean age of the subjects was greater than 60 years, 36 the other included a limited number of subjects: 18 diabetic patients and 16 healthy controls. 37 In the present study we observed a positive association of WBC count with serum glucose concentration among 3,594 apparently healthy men with a mean age of 50.4 years. When the finding that glucose alone modulates PMN activity 38 is taken into consideration, the inconsistency between the results of previous studies and ours may be related to the differences in the subjects or other unknown factors. Further studies on the association between glucose, HbA1c, and PMNs among healthy subjects are needed.
In summary, the WBC count within the normal range showed a significant and independent association with MS itself and its 5 components (ie, obesity, high blood pressure, hypertriglyceridemia, hypo-HDL-cholesterolemia, and hyperglycemia) as defined in ATP III, but not with the insulin concentration itself. The WBC count increased as the number of MS components increased. These results suggest that there is low-grade inflammation that progresses as the MS components become clustered. In the future, biological and epidemiological research on the association among WBC, MS and CVD is required to elucidate the mechanism of the WBC count increase and to establish its cutoff point as a prognostic indicator for CVD.
